1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Hansson, H.
Mattsson, P.T.
Allard, P.
Haapaniemi, P.
Vihinen, M.
Smith, C.I.E.
Hard, T.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
37
2912
2924
10.1021/bi972409f
9485443
Solution structure of the SH3 domain from Bruton's tyrosine kinase.
1998
10.2210/pdb1awx/pdb
pdb_00001awx
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
7772.562
BRUTON'S TYROSINE KINASE
2.7.1.112
SH3 DOMAIN
1
man
polymer
ATK, AGMX1, BPK
no
no
GSMSTSELKKVVALYDYMPMNANDLQLRKGDEYFILEESNLPWWRARDKNGQEGYIPSNYVTEAEDS
GSMSTSELKKVVALYDYMPMNANDLQLRKGDEYFILEESNLPWWRARDKNGQEGYIPSNYVTEAEDS
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
BLOOD
Escherichia
sample
9606
Homo sapiens
CYTOPLASM
562
Escherichia coli
PGEX-4T-3
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1998-04-08
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1997-10-06
REL
REL
MINIMIZED AVERAGE STRUCTURE BASED ON 42 LOWEST ENERGY STRUCTURES
50
1
NOESY
TOCSY
DQF-COSY
15N-TOCSY-HSQC
15N-NOESY-HSQC
HNHA
HNHB
6.5
303
K
THE STRUCTURE WAS DETERMINED USING 756 DISTANCE RESTRAINTS, 52 DIHEDRAL ANGLE RESTRAINTS AND 22 HYDROGEN BOND RESTRAINTS. THE HYDROGEN BOND RESTRAINTS WERE USED ONLY IN THE LAST STEP OF REFINEMENT. 50 STRUCTURES WERE CALCULATED AND REFINED USING AB INITIO SIMULATED ANNEALING PROTOCOL FOR X-PLOR (1). ALL FORCE CONSTANTS AND POTENTIALS WERE SET TO THE DEFAULT (PROTOCOL) VALUES EXCEPT FOR THE VAN DER WAALS' RADII SCALE FACTOR ("REPEL"), WHICH WAS DECREASED TO 0.80 INSTEAD OF 0.75 DURING THE FINAL COOLING STAGES IN THE REFINEMENT. THIS RESULTS IN MORE REASONABLE BACKBONE CONFORMATION AND SOMEWHAT HIGHER X-PLOR TOTAL ENERGIES. CENTER AVERAGING PSEUDOATOM CORRECTION WAS USED FOR ALL DISTANCE RESTRAINT S(2). ON THE BASIS OF X-PLOR TOTAL ENERGY 42 LOWEST ENERGY STRUCTURES WERE SELECTED. THE AVERAGE AND MINIMIZED STRUCTURE WAS CALCULATED BY AVERAGING SUPERIMPOSED STRUCTURES IN THE ENSEMBLE AND THEN ENERGY MINIMIZING THE AVERAGE STRUCTURE. THE POTENTIALS AND CONSTANTS USED IN THE ENERGY MINIMIZATION WERE THE SAME FOR THE AVERAGE STRUCTURE AND THE ENSEMBLE STRUCTURES.
AB INITIO - SIMULATED ANNEALING
BRUNGER
refinement
X-PLOR
3.851
structure solution
VNMR 4.3 AND
5.2
structure solution
ANSIG V.3.2
V.3.2
structure solution
X-PLOR V.3.851
V.3.851
500
Varian
UNITY 500
GLY
1
n
1
GLY
1
A
SER
2
n
2
SER
2
A
MET
3
n
3
MET
3
A
SER
4
n
4
SER
4
A
THR
5
n
5
THR
5
A
SER
6
n
6
SER
6
A
GLU
7
n
7
GLU
7
A
LEU
8
n
8
LEU
8
A
LYS
9
n
9
LYS
9
A
LYS
10
n
10
LYS
10
A
VAL
11
n
11
VAL
11
A
VAL
12
n
12
VAL
12
A
ALA
13
n
13
ALA
13
A
LEU
14
n
14
LEU
14
A
TYR
15
n
15
TYR
15
A
ASP
16
n
16
ASP
16
A
TYR
17
n
17
TYR
17
A
MET
18
n
18
MET
18
A
PRO
19
n
19
PRO
19
A
MET
20
n
20
MET
20
A
ASN
21
n
21
ASN
21
A
ALA
22
n
22
ALA
22
A
ASN
23
n
23
ASN
23
A
ASP
24
n
24
ASP
24
A
LEU
25
n
25
LEU
25
A
GLN
26
n
26
GLN
26
A
LEU
27
n
27
LEU
27
A
ARG
28
n
28
ARG
28
A
LYS
29
n
29
LYS
29
A
GLY
30
n
30
GLY
30
A
ASP
31
n
31
ASP
31
A
GLU
32
n
32
GLU
32
A
TYR
33
n
33
TYR
33
A
PHE
34
n
34
PHE
34
A
ILE
35
n
35
ILE
35
A
LEU
36
n
36
LEU
36
A
GLU
37
n
37
GLU
37
A
GLU
38
n
38
GLU
38
A
SER
39
n
39
SER
39
A
ASN
40
n
40
ASN
40
A
LEU
41
n
41
LEU
41
A
PRO
42
n
42
PRO
42
A
TRP
43
n
43
TRP
43
A
TRP
44
n
44
TRP
44
A
ARG
45
n
45
ARG
45
A
ALA
46
n
46
ALA
46
A
ARG
47
n
47
ARG
47
A
ASP
48
n
48
ASP
48
A
LYS
49
n
49
LYS
49
A
ASN
50
n
50
ASN
50
A
GLY
51
n
51
GLY
51
A
GLN
52
n
52
GLN
52
A
GLU
53
n
53
GLU
53
A
GLY
54
n
54
GLY
54
A
TYR
55
n
55
TYR
55
A
ILE
56
n
56
ILE
56
A
PRO
57
n
57
PRO
57
A
SER
58
n
58
SER
58
A
ASN
59
n
59
ASN
59
A
TYR
60
n
60
TYR
60
A
VAL
61
n
61
VAL
61
A
THR
62
n
62
THR
62
A
GLU
63
n
63
GLU
63
A
ALA
64
n
64
ALA
64
A
GLU
65
n
65
GLU
65
A
ASP
66
n
66
ASP
66
A
SER
67
n
67
SER
67
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
VAL
11
A
O
VAL
11
A
N
TYR
33
A
N
TYR
33
A
O
TRP
44
A
O
TRP
44
A
N
ILE
56
A
N
ILE
56
1
A
ARG
28
0.300
SIDE CHAIN
1
A
ARG
45
0.279
SIDE CHAIN
1
A
ARG
47
0.222
SIDE CHAIN
1
A
MET
3
52.82
91.10
1
A
SER
6
-59.56
-72.51
1
A
LEU
8
-161.33
115.68
1
A
LEU
14
-91.67
-70.95
1
A
TYR
17
-167.56
93.15
1
A
ASN
21
-125.35
-55.19
1
A
ALA
22
-170.66
-40.23
1
A
LEU
27
-79.77
-168.97
1
A
ARG
28
-169.99
-158.33
1
A
GLU
37
-123.81
-162.28
1
A
GLU
38
177.99
43.49
1
A
SER
39
-54.13
-171.18
1
A
TRP
44
-110.22
-161.66
1
A
ASP
48
-98.80
-152.70
1
A
LYS
49
-95.93
36.48
1
A
THR
62
-145.06
-133.42
model building
X-PLOR
3.851
refinement
X-PLOR
3.851
phasing
X-PLOR
3.851
SH3 DOMAIN FROM BRUTON'S TYROSINE KINASE, NMR, MINIMIZED AVERAGE STRUCTURE
1
Y
N
TRANSFERASE
TYROSINE KINASE, X-LINKED AGAMMAGLOBULINEMIA, XLA, BTK, SH3 DOMAIN, TRANSFERASE
BTK_HUMAN
UNP
1
1
Q06187
MAAVILESIFLKRSQQKKKTSPLNFKKRLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKITCVETVVPEKNPPPERQIP
RRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIRYNSDLVQKYHPCFWIDGQYLCCSQTAK
NAMGCQILENRNGSLKPGSSHRKTKKPLPPTPEEDQILKKPLPPEPAAAPVSTSELKKVVALYDYMPMNANDLQLRKGDE
YFILEESNLPWWRARDKNGQEGYIPSNYVTEAEDSIEMYEWYSKHMTRSQAEQLLKQEGKEGGFIVRDSSKAGKYTVSVF
AKSTGDPQGVIRHYVVCSTPQSQYYLAEKHLFSTIPELINYHQHNSAGLISRLKYPVSQQNKNAPSTAGLGYGSWEIDPK
DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG
CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP
VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADE
RPTFKILLSNILDVMDEES
212
275
1AWX
4
67
Q06187
A
1
4
67
2
2
anti-parallel
anti-parallel
A
LYS
10
A
LYS
10
A
VAL
12
A
VAL
12
A
GLU
32
A
GLU
32
A
PHE
34
A
PHE
34
A
TRP
43
A
TRP
43
A
ARG
47
A
ARG
47
A
GLU
53
A
GLU
53
A
PRO
57
A
PRO
57
1
P 1